Stempeutics Research
India - Bangalore
BiotechnologyFocus: Stem Cell Therapeutics
Stempeutics Research is a life sciences company focused on Stem Cell Therapeutics.
Cell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Stem cell
Myocardial InfarctionClinical Trials (1)
NCT00883727Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
Phase 1/2mesenchymal stem cells
Critical Limb IschemiaClinical Trials (1)
NCT00883870Mesenchymal Stem Cells in Critical Limb Ischemia
Phase 1/2Ex vivo cultured adult allogenic MSCs
StrokeClinical Trials (1)
NCT01091701Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke
Phase 1/2Allogeneic Mesenchymal Stem Cells
Alcoholic Liver CirrhosisClinical Trials (1)
NCT01591200Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
Phase 2Ex- vivo cultured adult allogeneic MSCs
Osteoarthritis of Knee JointClinical Trials (1)
NCT01448434Allogeneic Mesenchymal Stem Cells for Osteoarthritis
Phase 2Phase 2
Clinical Trials (1)
NCT03056742A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease
Phase 2Ex- vivo cultured adult allogeneic MSCs
Osteoarthritis of KneeClinical Trials (1)
NCT01453738Allogeneic Mesenchymal Stem Cells in Osteoarthritis
Phase 2Allogeneic Mesenchymal Stem Cells
Critical Limb IschemiaClinical Trials (1)
NCT01484574A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
Phase 2Stempeucel®
Critical Limb IschemiaClinical Trials (1)
NCT05854641Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
Phase 4Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells
Critical Limb IschemiaClinical Trials (1)
NCT05854615Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2022
Portfolio: 10 clinical trials